CBD edibles in Switzerland — the legal picture

TL;DR

• The FSVO classifies cannabinoid extracts as Novel Food (authorisation required).
• CBD oils are usually sold as aroma oils or cosmetics — not as food.
• THC in food: ARfD 1 µg/kg BW (EFSA), Switzerland aligns.
• Therapeutic claims are prohibited (TPA Art. 32).

Grey zone in practice

Many Swiss shops sell CBD oil as 'external use' or 'aroma oil' — a legally tolerated workaround. For CBD baked goods, Novel Food authorisation is still required and no brand in CH holds it.

Two regulatory frameworks: narcotics law and food law

For CBD edibles, two separate legal levels apply in Switzerland. Under narcotics law, only the total THC content matters: under 1 % is not a narcotic. Under food law, the hurdle is higher — cannabinoid-containing foods are considered novel foods and require authorization from the BLV. Therefore, many CBD products in Switzerland are explicitly not declared as food, but are instead placed on the market as aroma products or cosmetics, for example.

Added to this is active ingredient communication: health claims turn a food product into a medicinal product that requires Swissmedic authorization. A provider advertising CBD gummy bears for sleep disorders or pain is violating current law — and, experience shows, is also unlikely to be diligent with their analytics.

• Total THC of the final product under 1 %, verified by batch analysis
• Food status only with BLV authorization as a novel food
• No health claims without Swissmedic authorization
• EFSA reference dose for THC: 1 µg per kg of body weight per day

What to look out for specifically when buying

Four things can be verified: a batch number on the packaging, an associated certificate of analysis from an independent laboratory showing the total THC value, a complete list of ingredients including the carrier substance, and a clear indication in milligrams per piece instead of a percentage. If any of these are missing, neither legality nor dosage can be assessed. For travel abroad, the following also applies: the Swiss 1-% threshold is higher than the 0.2 to 0.3 % of most EU countries — legally purchased does not mean legally carried.

Swiss classification: Under food law, cannabinoid-containing foods are classified as novel foods and require authorization from the Federal Food Safety and Veterinary Office (BLV). Under narcotics law, the total THC value remains decisive: under 1% (THC + THCA × 0.877) it is not a narcotic. Anyone working in their own kitchen for personal use operates outside of food law — if the result is sold or given away, it is immediately considered placing on the market.

Home production in the private kitchen and the question of liability

Anyone who makes CBD edibles such as biscuits or chocolates in their own kitchen for purely personal use is operating within a legally protected private framework. The strict Swiss food law does not apply in this case, as there is no commercial placing on the market. However, it is important that the starting products used, such as CBD flowers or extracts, do not exceed the legal limit of less than one percent total THC in order to avoid falling under the Narcotics Act. Careful processing is advisable, as the active ingredients decarboxylate when heated and the intensity can change unexpectedly.

The legal situation changes abruptly as soon as homemade products are passed on to third parties. Even giving them away free of charge to friends can be legally classified as placing them on the market, making the strict liability rules of food and product safety law applicable. Should a person experience adverse effects after consumption, the manufacturer bears the responsibility. In case of uncertainty or accidental overdose, Tox Info Suisse provides round-the-clock medical advice for those affected and their relatives in Switzerland via the emergency number 145.

• Pure personal consumption and private production are not subject to food law.
• Passing products on to third parties (even free of charge) is legally considered placing them on the market.
• Starting materials must strictly remain below the limit of one percent total THC.
• In case of intolerances or overdoses, Tox Info Suisse (telephone 145) provides immediate assistance.

Road safety and the Swiss zero-tolerance practice

The consumption of CBD edibles has a direct impact on the ability to drive in Swiss road traffic. Although CBD itself is not psychoactive, full-spectrum products often contain minor traces of THC, which can accumulate in the body. In Switzerland, a strict zero-tolerance practice applies to THC behind the wheel. The statutory detection limit is an extremely low 1.5 micrograms of THC per litre of blood. If this limit is exceeded during a police check, the person concerned is legally deemed unfit to drive, resulting in the revocation of their driving licence and severe penalties.

A major risk with edibles is the delayed absorption of active ingredients via the gastrointestinal tract, which often only begins after one to two hours. Consumers frequently underestimate the duration of action and the accumulation in the organism. Anyone who regularly consumes supposedly THC-free edibles risks their blood THC level exceeding the strict limit, even if there is no noticeable impairment. For safe participation in road traffic, it is therefore advisable to completely refrain from driving vehicles after consuming products containing cannabinoids.

• Strict zero-tolerance policy in Swiss road traffic with a limit of 1.5 micrograms of THC per litre of blood.
• Delayed effects of edibles often lead to misjudgements regarding fitness to drive.
• Minor traces of THC in full-spectrum CBD products can accumulate in the body.
• Unfitness to drive can be established solely through analytical detection, even without any noticeable psychoactive effect.

Cantonal enforcement and official control measures

Although the Narcotics Act and food law are regulated at the federal level, practical enforcement lies with the individual cantons. In Switzerland, this leads to inconsistent handling of inspections and sanctions. Cantonal laboratories and food control authorities regularly carry out spot checks at points of sale. Products that are falsely declared as food or exceed the permissible total THC limit are consistently confiscated and withdrawn from the market. In such cases, distributors face administrative and criminal consequences.

Cantonal nuances are also evident in the area of consumption. Although the federal government provides for a fixed penalty fine of one hundred francs for adults consuming illegal THC cannabis, provided the quantity carried is under ten grams, how tolerantly local police forces proceed in distinguishing between CBD- and THC-containing products varies greatly depending on the canton. Since edibles cannot be visually distinguished from ordinary food, inspections often lead to costly laboratory analyses to determine the actual THC content of the confiscated product beyond doubt.

• The enforcement of food and narcotics law is the responsibility of the cantonal authorities.
• Cantonal laboratories test spot samples and initiate sales bans in the event of violations.
• Consumption controls and the enforcement of fixed penalty fines vary depending on cantonal practice.
• In cases of suspicion, edibles require expensive laboratory analyses to determine the exact THC content.

Distinction from medical cannabis and the Swiss pilot trials

CBD edibles from the open market must not be confused with medical cannabis or products from state-approved pilot trials. Since August 2022, medical cannabis has been directly prescribable by doctors in Switzerland without an exceptional permit from the Federal Office of Public Health. These medical preparations are subject to the strictest quality controls by Swissmedic and are used specifically for therapeutic purposes. Over-the-counter CBD products do not have this medical approval and may therefore not be advertised with health-related claims.

In parallel, time-limited cannabis pilot trials are running in various Swiss cities, such as Züri Can or Weed Care in Basel. These scientific studies, which are based on Article 8b of the Narcotics Act, investigate the regulated sale of THC-containing cannabis for recreational purposes. The products offered there, which may also include edibles in some cases, are reserved exclusively for registered study participants. They serve the purpose of scientific data collection and are by no means to be equated with the freely available CBD products on the general market.

• Medical cannabis has been medically prescribable without a BAG exceptional permit since August 2022.
• Over-the-counter CBD edibles are not approved medicinal products and have no medical indication.
• Scientific pilot trials with THC cannabis are strictly regulated and limited in time.
• Participation in pilot studies requires official registration and is locally restricted.

FAQ